Literature DB >> 25556270

Identification of microRNAs and target genes involved in serous ovarian carcinoma and their influence on survival.

L Wang1, B Wang, M Fang, F Guo, M Cui.   

Abstract

AIMS: To identify the expression of key microRNAs and their predicted target genes involved in serous ovarian carcinoma (SOC) and correlation between miRNAs and prognosis.
MATERIALS AND METHODS: The authors used quantitative polymerase chain reaction (qPCR) to detect the expression of miR-145, miR-143, miR-146a, miR-93, miR-29a, miR-18a, and miR-200a in tissues of 56 primary SOC patients and 30 benign lesion patients. Four protein (MUC1, FAP, MMP2, MMP9) expressions were identified by western blotting and immunohistochemical stain. The Kaplan-Meier method was used to estimate the relationship of these miRNAs with overall survival rate.
RESULTS: In SOC tissue, expression of miR-200a, miR-93, miR-146a, and miR-18a were up-regulated, while miR-145, miR-143, miR-29a were down-regulated. MUC1, FAP, MMP2, and MMP9 were overexpressed in SOC. MiR-143 or miR-145 higher expressed patients had significantly higher overall survival (OS) rates, while miR-93 or miR-200a lower expressed patients also had higher OS rates. DISCUSSION: These results suggested that several miRNAs and their regulated target transcripts may have important roles in the initiation and development of SOC. MiR-145/miR-143, miR-200a, and miR-93 could be used as prognostic biomarkers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25556270

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  8 in total

Review 1.  Good or not good: Role of miR-18a in cancer biology.

Authors:  Tomasz Kolenda; Kacper Guglas; Magda Kopczyńska; Joanna Sobocińska; Anna Teresiak; Renata Bliźniak; Katarzyna Lamperska
Journal:  Rep Pract Oncol Radiother       Date:  2020-08-12

2.  miR-761 inhibits tumor progression by targeting MSI1 in ovarian carcinoma.

Authors:  Can Shi; Zhenyu Zhang
Journal:  Tumour Biol       Date:  2015-11-12

3.  MicroRNA-584 inhibits cell proliferation and invasion in non-small cell lung cancer by directly targeting MTDH.

Authors:  Yixiang Zhang; Yanjun Wang; Jinguang Wang
Journal:  Exp Ther Med       Date:  2017-12-12       Impact factor: 2.751

4.  MicroRNA-326 suppresses the proliferation, migration and invasion of cervical cancer cells by targeting ELK1.

Authors:  Ping Zhang; Feng Kong; Xinchao Deng; Yunhai Yu; Congzhe Hou; Tingting Liang; Lin Zhu
Journal:  Oncol Lett       Date:  2017-03-13       Impact factor: 2.967

5.  miR-584 inhibits cell proliferation, migration and invasion in vitro and enhances the sensitivity to cisplatin in human cervical cancer by negatively targeting GLI1.

Authors:  Tingfeng Wang; Juan Feng; Aiyun Zhang
Journal:  Exp Ther Med       Date:  2020-01-14       Impact factor: 2.447

Review 6.  The miR-200 family in ovarian cancer.

Authors:  Maria Koutsaki; Massimo Libra; Demetrios A Spandidos; Apostolos Zaravinos
Journal:  Oncotarget       Date:  2017-06-02

7.  Defining fallopian tube-derived miRNA cancer signatures.

Authors:  Selam B Dejene; Anders W Ohman; Wei Du; Deepinder Randhawa; Anand Bradley; Niraj Yadav; Kevin M Elias; Daniela M Dinulescu; Sunita R Setlur
Journal:  Cancer Med       Date:  2019-09-10       Impact factor: 4.452

Review 8.  Small Non-Coding-RNA in Gynecological Malignancies.

Authors:  Shailendra Kumar Dhar Dwivedi; Geeta Rao; Anindya Dey; Priyabrata Mukherjee; Jonathan D Wren; Resham Bhattacharya
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.